Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer
Public ClinicalTrials.gov record NCT00942968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
FRAG-A001-401: Dalteparin Sodium Injection (Fragmin), Multicenter, Open-Label, Single-arm, Long Term (52 Weeks) Study for Understanding the Safety and Efficacy in Subjects With Malignancies and Symptomatic Venous Thromboembolism
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the long term tolerability and safety of dalteparin in subjects with cancer.
Study identification
- NCT ID
- NCT00942968
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 338 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2009 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Jun 2013 (Actual)
- Last update posted
- Apr 18, 2024
2009 – 2013
United States locations
- U.S. sites
- 21
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Cancer Center | Tucson | Arizona | 85719 | — |
| Bay Area Cancer Research Group | Pleasant Hill | California | 94523 | — |
| Harbor-UCLA Medical Center | Torrance | California | 90509 | — |
| University of CT Health Center | Farmington | Connecticut | 6030 | — |
| Eastern Connecticut Hematology and Oncology Associates | Norwich | Connecticut | 6360 | — |
| Georgetown University Hospital-Lombardi Cancer Ctr | Washington D.C. | District of Columbia | 20007 | — |
| Halifax Health | Daytona Beach | Florida | 32114 | — |
| Atlanta Institute for Medical Research | Decatur | Georgia | 30030 | — |
| Orchard Healthcare Research Inc. | Skokie | Illinois | 60076 | — |
| James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| Bringham and Women's Hospital | Boston | Massachusetts | 2115 | — |
| Henry Ford Hospital K-15 | Detroit | Michigan | 48202 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Stony Brook University, Medical Center | Stony Brook | New York | 11794 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| MidDakota Clinic | Bismarck | North Dakota | 58501 | — |
| Pennsylvania Oncology Hematology Associates | Philadelphia | Pennsylvania | 19106 | — |
| MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Vermont Cancer Center at Fletcher Allen Health Care | Burlington | Vermont | 5401 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00942968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2024 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00942968 live on ClinicalTrials.gov.